Abstract:Acute sleep deprivation has been shown to affect cerebrospinal fluid and plasma concentrations of biomarkers associated with neurodegeneration, though the mechanistic underpinnings remain unknown. This study compared individuals who, for one night, were either subject to total sleep deprivation or free sleep, (i) examining plasma concentrations of neurodegeneration biomarkers the morning after sleep deprivation or free sleep and (ii) determining how overnight changes in biomarkers plasma concentrations correlate with indices of meningeal lymphatic and glymphatic clearance functions. Plasma concentrations of amyloid-β 40 and 42, phosphorylated tau peptide 181, glial fibrillary acid protein and neurofilament light were measured longitudinally in subjects who from Day 1 to Day 2 either underwent total sleep deprivation (n = 7) or were allowed free sleep (n = 21). The magnetic resonance imaging contrast agent gadobutrol was injected intrathecally, serving as a cerebrospinal fluid tracer. Population pharmacokinetic model parameters of gadobutrol cerebrospinal fluid-to-blood clearance were utilized as a proxy of meningeal lymphatic clearance capacity and intrathecal contrast-enhanced magnetic resonance imaging as a proxy of glymphatic function. After one night of acute sleep deprivation, the plasma concentrations of amyloid-β 40 and 42 were reduced, but not the ratio, and concentrations of the other biomarkers were unchanged. The overnight change in amyloid-β 40 and 42 plasma concentrations in the sleep group correlated significantly with indices of meningeal lymphatic clearance capacity, while this was not seen for the other neurodegeneration biomarkers. However, overnight change in plasma concentrations of amyloid-β 40 and 42 did not correlate with the glymphatic marker. On the other hand, the overnight change in plasma concentration of phosphorylated tau peptide 181 correlated significantly with the marker of glymphatic function in the sleep deprivation group but not in the sleep group. The present data add to the evidence of the role of sleep and sleep deprivation on plasma neurodegeneration concentrations; however, the various neurodegeneration biomarkers respond differently with different mechanisms behind sleep-induced alterations in amyloid-β and tau plasma concentrations. Clearance capacity of meningeal lymphatics seems more important for sleep-induced changes in amyloid-β 40 and 42 plasma concentrations, while glymphatic function seems most important for change in plasma concentration of phosphorylated tau peptide 181 during sleep deprivation. Altogether, the present data highlight diverse mechanisms behind sleep-induced effects on concentrations of plasma neurodegeneration biomarkers.

Exploring gene expression biomarker candidates for neurobehavioral impairment from total sleep deprivation

0030 Gene Expression and Attention Lapses with a Countermeasure for Sleep Loss

Molecular and anatomical signatures of sleep deprivation in the mouse brain

Identification of Potential Gene Signatures Related to Sleep Deprivation

Behavioral and genetic markers of sleepiness

Spatial transcriptomics reveals unique gene expression changes in different brain regions after sleep deprivation

0172 Predictive Relationships Between Baseline and Recovery Sleep and Neurobehavioral Measures During Sleep Deprivation

Altered hippocampal transcriptome dynamics following sleep deprivation

Genomic analysis of sleep deprivation reveals translational regulation in the hippocampus

Blood-Gene Expression Reveals Reduced Circadian Rhythmicity in Individuals Resistant to Sleep Deprivation

Multiplex influences on vigilance and biochemical variables induced by sleep deprivation

Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation

Multiomics analysis of human peripheral blood reveals marked molecular profiling changes caused by one night of sleep deprivation

From Sleep Deprivation to Severe COVID-19: A Comprehensive Analysis of Shared Differentially Expressed Genes and Potential Diagnostic Biomarkers

Neurophysiological Effects of Sleep Deprivation in Healthy Adults, a Pilot Study

Longitudinal transcriptome-wide gene expression analysis of sleep deprivation treatment shows involvement of circadian genes and immune pathways

The dynamic gene regulatory landscape of the mouse brain in response to sleep deprivation

A global transcriptional atlas of the effect of acute sleep deprivation in the mouse frontal cortex

Association between Enhanced Effective Connectivity from the Cuneus to the Middle Frontal Gyrus and Impaired Alertness after Total Sleep Deprivation

Transcriptional Dynamics of Sleep Deprivation and Subsequent Recovery Sleep in the Male Mouse Cortex

Sleep deprivation and neurobehavioral dynamics